Tutkimukseen rekrytoidaan n. 400 dyspepsiaoireiden vuoksi erikoissairaanhoitoon lähetettyä alle 60-vuotiasta potilasta, joiden vaiva tutkimusten jälkeen todetaan toiminnalliseksi. MedDRA version: 9.1 Level: LLT Classification code 10013946 Term: Dyspepsia
Conditions
Interventions
Trade Name: Citalopram-Ratiopharm
Pharmaceutical Form:
INN or Proposed INN: CITALOPRAM
CAS Number: 59729338
Pharmaceutical form of the placebo: Capsule*
Route of administration of the placebo: Oral u
Sponsors
Kuopio University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Kts. yst. tutkimussuunnitelma kohtien E3-5 osalta Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Kts. yst. tutkimussuunnitelma;Secondary Objective: Kts. yst. tutkimussuunnitelma;Primary end point(s): | — |
Countries
Finland
Outcome results
None listed